# Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers

> **NCT00003249** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** carboxyamidotriazole
- **DRUG:** chemotherapy
- **DRUG:** ketoconazole

## Key facts

- **NCT ID:** NCT00003249
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2001-12
- **Final completion:** —
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003249, "Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00003249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*